Literature DB >> 24925099

Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.

Ishla Seager1, Simon A Travers, Michael D Leeson, Amelia C Crampin, Neil French, Judith R Glynn, Grace P McCormack.   

Abstract

There are few cohorts of individuals who have survived infection with HIV-1 for more than 20 years, reported and followed in the literature, and even fewer from Africa. Here we present data on a cohort of subtype C-infected individuals from rural northern Malawi. By sequencing multiple clones from long-term survivors at different time points, and using multiple genotyping approaches, we show that 5 of the 11 individuals are predicted as CXCR4 using (by ≥3/5 predictors) but only one individual is predicted as CXCR4 using by all five algorithms. Using any one genotyping approach overestimates the number of predicted CXCR4 sequences. Patterns of diversity and divergence were variable between the HIV-1 long-term survivors with some individuals showing very small amounts of variation and change, and others showing a greater amount; both patterns are consistent with what has been described in the literature.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24925099      PMCID: PMC4180525          DOI: 10.1089/aid.2013.0240

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  60 in total

1.  First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection.

Authors:  Bin Wang; Meriet Mikhail; Wayne B Dyer; John J Zaunders; Anthony D Kelleher; Nitin K Saksena
Journal:  Virology       Date:  2003-07-20       Impact factor: 3.616

2.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

3.  HIV type 1 mutational patterns in HIV type 1 subtype C-infected long-term survivors in Karonga District Malawi: further analysis and correction.

Authors:  Ishla Seager; Michael D Leeson; Amelia C Crampin; Dominic Mulawa; Neil French; Judith R Glynn; Simon A A Travers; Grace P McCormack
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-30       Impact factor: 2.205

4.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Authors:  Olivier Lambotte; Faroudy Boufassa; Yoann Madec; Ahn Nguyen; Cécile Goujard; Laurence Meyer; Christine Rouzioux; Alain Venet; Jean-François Delfraissy
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

5.  In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.

Authors:  Andreas Jekle; Oliver T Keppler; Erik De Clercq; Dominique Schols; Mark Weinstein; Mark A Goldsmith
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4.

Authors:  Katherine Michler; Bridgette J Connell; Willem D F Venter; Wendy S Stevens; Alexio Capovilla; Maria A Papathanasopoulos
Journal:  AIDS Res Hum Retroviruses       Date:  2008-05       Impact factor: 2.205

7.  Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies.

Authors:  Martine Braibant; Henri Agut; Christine Rouzioux; Dominique Costagliola; Brigitte Autran; Francis Barin
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

8.  The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

Authors:  Tonie Cilliers; Jabulani Nhlapo; Mia Coetzer; Dragana Orlovic; Thomas Ketas; William C Olson; John P Moore; Alexandra Trkola; Lynn Morris
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.

Authors:  Nina H Lin; Carlos Becerril; Francoise Giguel; Vladimir Novitsky; Sikhulile Moyo; Joseph Makhema; Myron Essex; Shahin Lockman; Daniel R Kuritzkes; Manish Sagar
Journal:  Virology       Date:  2012-09-03       Impact factor: 3.616

10.  Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda.

Authors:  Oliver Laeyendecker; Andrew D Redd; Tom Lutalo; Ronald H Gray; Maria Wawer; Victor Ssempijja; Jordyn Gamiel; John Baptist Bwanika; Fred Makumbi; Fred Nalugoda; Pius Opendi; Godfrey Kigozi; Anthony Ndyanabo; Boaz Iga; Noah Kiwanuka; Nelson Sewankambo; Steven J Reynolds; David Serwadda; Thomas C Quinn
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11-01       Impact factor: 3.731

View more
  2 in total

1.  Individuals with HIV-1 Subtype C Infection and Cryptococcal Meningitis Exhibit Viral Genetic Intermixing of HIV-1 Between Plasma and Cerebrospinal Fluid and a High Prevalence of CXCR4-Using Variants.

Authors:  Katlego Sojane; Richard T Kangethe; Christina C Chang; Mahomed-Yunus S Moosa; Sharon R Lewin; Martyn A French; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2018-05-23       Impact factor: 2.205

2.  Viruses Previously Identified in Brazil as Belonging to HIV-1 CRF72_BF1 Represent Two Closely Related Circulating Recombinant Forms, One of Which, Designated CRF122_BF1, Is Also Circulating in Spain.

Authors:  Javier E Cañada-García; Elena Delgado; Horacio Gil; Sonia Benito; Mónica Sánchez; Antonio Ocampo; Jorge Julio Cabrera; Celia Miralles; Elena García-Bodas; Ana Mariño; Patricia Ordóñez; María José Gude; Carmen Ezpeleta; Michael M Thomson
Journal:  Front Microbiol       Date:  2022-05-27       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.